Vanda Pharmaceuticals Inc (VNDA)
4.88
+0.20
(+4.27%)
USD |
NASDAQ |
May 03, 16:00
5.05
+0.17
(+3.48%)
After-Hours: 20:00
Vanda Pharmaceuticals Cash and Short Term Investments (Quarterly): 388.26M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 388.26M |
| September 30, 2023 | 489.86M |
| June 30, 2023 | 489.35M |
| March 31, 2023 | 501.50M |
| December 31, 2022 | 466.86M |
| September 30, 2022 | 454.79M |
| June 30, 2022 | 440.86M |
| March 31, 2022 | 435.18M |
| December 31, 2021 | 432.81M |
| September 30, 2021 | 405.97M |
| June 30, 2021 | 396.49M |
| March 31, 2021 | 378.16M |
| December 31, 2020 | 367.74M |
| September 30, 2020 | 348.55M |
| June 30, 2020 | 339.85M |
| March 31, 2020 | 312.33M |
| December 31, 2019 | 312.13M |
| September 30, 2019 | 237.78M |
| June 30, 2019 | 280.16M |
| March 31, 2019 | 267.84M |
| December 31, 2018 | 257.36M |
| September 30, 2018 | 240.58M |
| June 30, 2018 | 231.22M |
| March 31, 2018 | 248.83M |
| December 31, 2017 | 143.41M |
| Date | Value |
|---|---|
| September 30, 2017 | 139.88M |
| June 30, 2017 | 137.12M |
| March 31, 2017 | 137.76M |
| December 31, 2016 | 141.34M |
| September 30, 2016 | 142.58M |
| June 30, 2016 | 135.99M |
| March 31, 2016 | 138.33M |
| December 31, 2015 | 143.18M |
| September 30, 2015 | 144.32M |
| June 30, 2015 | 146.64M |
| March 31, 2015 | 134.33M |
| December 31, 2014 | 129.82M |
| September 30, 2014 | 56.09M |
| June 30, 2014 | 63.58M |
| March 31, 2014 | 100.40M |
| December 31, 2013 | 130.35M |
| September 30, 2013 | 142.17M |
| June 30, 2013 | 103.63M |
| March 31, 2013 | 110.93M |
| December 31, 2012 | 120.40M |
| September 30, 2012 | 134.40M |
| June 30, 2012 | 144.70M |
| March 31, 2012 | 157.25M |
| December 31, 2011 | 148.88M |
| September 30, 2011 | 161.45M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
237.78M
Minimum
Sep 2019
501.50M
Maximum
Mar 2023
393.61M
Average
396.49M
Median
Jun 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| ADMA Biologics Inc | 51.35M |
| INVO Bioscience Inc | 0.2324M |
| Johnson & Johnson | 26.22B |
| Nektar Therapeutics | 303.62M |
| Invivyd Inc | 200.64M |